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A number of neglected tropical diseases are targeted for elimination or eradication. An effec-
tive surveillance system is critical to determine if these goals have been achieved and main-
tained. Trachoma has two related but morphologically different presentations that are
monitored for elimination, the active infectious form of trachoma and trachomatous trichiasis
(TT), the progression of the disease. There are a number of lessons learnt from the Guinea
worm surveillance system that are particularly compatible for TT surveillance and the oncho-
cerciasis surveillance system which can provide insights for surveillance of the infectious
form of trachoma.
Methods/Principal findings
A literature search of peer-reviewed published papers and grey literature was conducted
using PUBMED and Google Scholar for articles relating to dracunculiasis or Guinea worm,
onchocerciasis and trachoma, along with surveillance or elimination or eradication. The
abstracts of relevant papers were read and inclusion was determined based on specified
inclusion and exclusion criteria. The credibility and bias of relevant papers were also criti-
cally assessed using published criteria. A total of 41 papers were identified that were eligible
for inclusion into the review.
The Guinea worm programme is designed around a surveillance-containment strategy
and combines both active and passive surveillance approaches, with a focus on village-
based surveillance and reporting. Although rumour reporting and a monetary incentive for
the identification of confirmed Guinea worm cases have been reported as successful for
identifying previously unknown transmission there is little unbiased evidence to support this
conclusion. More rigorous evidence through a randomised controlled trial, influenced by
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motivational factors identified through formative research, would be necessary in order to
consider applicability for TT case finding in an elimination setting. The onchocerciasis sur-
veillance strategy focuses on active surveillance through sentinel surveillance of villages
and breeding sites. It relies on an entomological component, monitoring infectivity rates of
black flies and an epidemiological component, tracking exposure to infection in humans.
Challenges have included the introduction of relatively complex diagnostics that are not
readily available in onchocerciasis endemic countries and target thresholds, which are prac-
tically unattainable with current diagnostic tests. Although there is utility in monitoring for
infection and serological markers in trachoma surveillance, it is important that adequate con-
siderations are made to ensure evidence-based and achievable guidelines for their utility
are put in place.
Conclusions/Significance
The experiences of both the Guinea worm and onchocerciasis surveillance strategies have
very useful lessons for trachoma surveillance, pre- and post-validation. The use of a mone-
tary reward for identification of TT cases and further exploration into the use of infection and
serological indicators particularly in a post-validation setting to assist in identifying recrudes-
cence would be of particular relevance. The next step would be a real-world evaluation of
their relative applicability for trachoma surveillance.
Author summary
The design of a surveillance system needs to be carefully thought out to ensure it provides
sufficient evidence to determine if a disease or infection is eliminated or eradicated. If
inappropriate it can lead to on-going transmission and resurgence of infection or disease
or the unnecessary continuation of interventions, wasting valuable resources. Guinea
worm is a disease that is painful and debilitating, for which there is no drug or vaccine.
The aim is to eradicate the disease and as such the Guinea worm programme is designed
around a strategy of identification of cases and their containment to prevent onward
transmission. Onchocerciasis if left untreated can lead to blindness. The aim is to elimi-
nate the disease through the interruption of transmission. A literature review was con-
ducted to determine available evidence and identify lessons that can be learnt from the
surveillance of both diseases for the design of trachoma surveillance strategies in the end-
game. The potential utility of rumour reporting and a monetary incentive for the identifi-
cation of a confirmed case of Guinea worm could be explored for trichiasis case finding.
Trichiasis is the progression of trachoma and leads to significant ocular morbidity. The
introduction of tests for infection and antibodies and the utility of sentinel surveillance as
utilised for onchocerciasis are interesting considerations for active trachoma surveillance
post-validation and has potential to identify recrudescence cost-effectively. The experi-
ences of both the Guinea worm and onchocerciasis surveillance strategies have very useful
lessons that can be trialled for trachoma surveillance. However, their real-world applica-
bility and implications for trachoma need to be evaluated before any changes in guidelines
are proposed.
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Introduction
The 2012 World Health Organisation (WHO) roadmap on neglected tropical diseases
(NTDs) outlines an ambitious plan for the control, elimination and eradication of at least
17 diseases [1], further endorsed by the London Declaration on NTDs [2]. Three of these
NTDs include dracunculiasis, commonly known as Guinea worm, which along with yaws is
one of two NTDs targeted for eradication; onchocerciasis targeted for elimination (inter-
ruption of transmission) in the majority of African countries and trachoma targeted for
elimination as a public health problem, all by 2030 [3]. Determining whether a disease is
suitable for eradication or elimination takes into account a number of factors, including
transmission dynamics, availability and performance of diagnostic tests and interventions
[4,5].
The WHO defines eradication as “the permanent reduction to zero of the worldwide inci-
dence of infection caused by a specific pathogen established in a human or animal population,
as a result of deliberate efforts, with no more risk of reintroduction” [6]. To date eradication
has only been achieved in the case of smallpox [7] and rinderpest [8]. Once eradication is
achieved worldwide, routine interventions and surveillance can be stopped. Elimination refers
to the reduction in infection or transmission to zero or to the degree that interventions can
stop in a defined geographical area, although post-elimination surveillance must continue
[9,10].
For each disease a specific surveillance system has been designed in order to provide the
required evidence that elimination or eradication targets have been achieved and interventions
can stop. The sensitivity of such a system is important in order to ensure that elimination or
eradication thresholds have been achieved and interventions are not stopped prematurely,
risking recrudescence. In an eradication programme or where the goal is interruption of trans-
mission, it is vital to have extremely sensitive surveillance measures to provide confidence that
all cases are detected [11]. Specificity of a surveillance system is also important in order to
limit the proportion of false positives and ensure that interventions do not continue unneces-
sarily, or that declaration of elimination or eradication is not delayed, both scenarios poten-
tially wasting limited resources [12].
This paper will review the structure and performance of the various surveillance strategies
utilised by Guinea worm eradication and onchocerciasis elimination programmes and discuss
the utility of the approaches for trachoma surveillance. NTD monitoring can be categorised
into four phases, mapping to establish disease prevalence at baseline, progress or impact moni-
toring after interventions have started, evaluation of stopping decisions to determine if elimi-
nation or eradication thresholds have been reached and post-intervention or elimination
surveillance to monitor for recrudescence [12]. This paper will only focus on surveillance
related to the latter two phases. Information on the three diseases, their transmission and rec-
ommended interventions are summarised in Table 1.
As country programmes progress along the trachoma elimination pathway, it is imperative
that evidence-based guidance is available, summarising the most effective surveillance strate-
gies to identify recrudescence of infection or disease. Guidance for pre-validation surveillance
has in part been guided by expert opinion due to a lack of available evidence in some areas,
such as the shift in strategy from continuous active surveillance of trachomatous—inflamma-
tion follicular (TF) in sentinel communities (post-MDA stopping) [23] to the repeat of a popu-
lation-based survey only [24]. There are currently no formal guidelines on post-validation
trachoma surveillance and a paucity of information on risks of recrudescence, hampering their
development. Where evidence is lacking it is possible to learn lessons in regards to strategies
from other disease surveillance programmes. The clinical progression of trachoma with the
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active infectious form of trachoma and TT, the progression of the disease, two related but mor-
phologically different presentations monitored for elimination, adds complexity to trachoma
surveillance, which require alternative surveillance strategies. There are a number of lessons
learnt from the Guinea worm surveillance system that are particularly compatible for TT sur-
veillance while the surveillance of onchocerciasis can provide insights for surveillance of the
active infectious form of trachoma.
Methodology
A literature search of peer-reviewed published papers and grey literature was conducted using
PUBMED and Google Scholar. The search strategy used search terms specific to each disease,
‘dracunculiasis’ or ‘Guinea worm’, ‘onchocerciasis’ and ‘trachoma’ in combination with ‘sur-
veillance’ or ‘elimination’ or ‘eradication’. A more general search for ‘neglected tropical dis-
ease’ and ‘surveillance’ was also included. All search terms and their variations are outlined in
the supplementary information (S1 Table). The search was conducted in July 2019, there was
no retrospective date restriction to the sources identified.
The abstracts of papers retrieved following the search were read and reviewed against a set
of inclusion criteria.
Table 1. A summary of the disease profiles and current interventions for trachoma, Guinea worm and onchocerciasis.
Trachoma Guinea worm Onchocerciasis
Causative agent Chlamydia trachomatis (Ct) (bacterium) Dracunculus medinensis (parasitic worm) Onchocerca volvulus (filarial nematode)
Significant morbidity Trachomatous trichiasis (TT), the in-turning
of the eyelashes so they touch the globe of the
eye, scratching the cornea and leading
directly or indirectly to corneal opacity
Slow and painful emergence of the female
nematode, usually on the lower limbs
Inflammation in the eye can lead to
significant ocular morbidity or blindness
Primary transmission
route
Direct contact through fomites and fingers or
eye-seeking flies [13].
Drinking stagnant water contaminated with
copepods containing the infective D.
medinensis larvae. An unusual epidemiology in
Chad, with dogs infected with Guinea worm
genetically indistinguishable from D.
medinensis and simultaneous sporadic
unlinked infections in humans, suggested an
alternative transmission cycle and the potential
of a paratenic or transport host [14]
Bite of an infected blackfly of the genus
Simulium, which breed in fast-flowing water
[15]
Reservoir of infection Humans Primarily humans but infections also identified





WHO-endorsed SAFE strategy (S—surgical
intervention for trichiasis; A—antibiotics to
treat active infection, F—facial cleanliness
and E–environmental improvements) [17]
No known anti-helminthic medication or
vaccine. Reliance on the rapid identification
and containment of cases, effective behaviour
change strategies, improved potable water
supply and vector control through the
treatment of infected water using an effective
larvicide [18]
Long-term annual or semi-annual mass





As of September 2020, ten countries have
been validation as eliminated trachoma as a
public health problem, seven in Asia
(Cambodia, China, Islamic Republic of Iran,
Lao People’s Democratic Republic, Myanmar,
Nepal and Oman), one in South America
(Mexico) and two in Africa (Ghana and
Morocco) [20,21]
There has been huge progress towards Guinea
worm eradication, with 3.5 million cases
reported in the 1980s, down to only 28 cases by
the end of 2018 [6]. However, the endgame has
taken longer than expected and challenges
remain. In 2018, the first ever case of Guinea
worm was identified in Angola, approximately
2000 kilometres away from any known
endemic area [6]
Onchocerciasis elimination has made great
strides in the Americas and although
onchocerciasis blindness as a result of
infection is no longer a public health
problem across the majority of Africa, the
goal of elimination and interruption of
transmission has had more limited successes
[22]
https://doi.org/10.1371/journal.pntd.0009082.t001
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Inclusion criteria
Papers were included in the review, if they
• referred to one of the diseases under study (Guinea worm, onchocerciasis or trachoma);
• described international or national frameworks or surveillance guidelines;
• presented experiences in using national or local surveillance strategies for elimination or for
a stop-intervention decision;
• presented primary research or data related to an evaluation of the performance of the sur-
veillance system;
• available in the English language.
Exclusion criteria.
Papers were excluded from the review, if they
• were purely descriptive progress reports on case numbers or findings of impact assessments
for routine or WHO recommended approaches;
• evaluated or compared the performance of specific diagnostic tests;
• referred to baseline mapping or pre-control surveillance only;
• referred to developed countries only.
Where articles presented evaluation findings (qualitative or a randomised controlled trial
(RCT)), these were critically reviewed for quality and strength of evidence using the appropri-
ate critical appraisal skills programme checklist [25]. Surveys were reviewed using the Center
for Evidence-based Management critical appraisal of a survey tool [26]. Based on the assess-
ment, papers were credited as one of three categories, i) likely credible or low risk of bias, ii)
unclear credibility or risk of bias and iii) unlikely credible or high risk of bias. Guidelines and
papers outlining country experiences were excluded from the critical appraisal.
Findings
A total of 41 papers met inclusion criteria and were included in the review, 14 relating to
Guinea worm, 8 relating to onchocerciasis, 18 relating to trachoma and one relating to more
than one of these diseases. Of these, 17 were primary studies or evaluations relating to surveil-
lance performance, 12 were descriptions of country experiences, eight presented guidelines or
frameworks for elimination surveillance, two were modelling papers and two were reviews of
applicability of current guidelines. Of the primary studies or evaluations, two were qualitative
studies, three used mixed methods, 10 were cross-sectional surveys, and two were RCTs, all 17
of which were critically appraised. Out of these, 13 were deemed as credible and a low risk of
bias, one had low credibility and high risk of bias and for three there was unclear credibility
and risk of bias. The main reasons for low or unclear credibility were the lack of information
on methodology or tools and limited consideration of potential sources of bias. The papers
included in the review are outlined in the supplementary information (S2 Table).
i. Overview of surveillance systems
The three diseases included in this review have different global targets, which influence the
design of the surveillance strategies. Guinea worm is targeted for eradication, with surveillance
designed around a case-based surveillance-containment strategy. It is imperative that cases are
quickly identified (ideally within 24 hours), confirmed and contained before onward
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transmission [27]. The Guinea worm programme combines the use of both active and passive
surveillance approaches, with a focus on village-based surveillance and reporting. It relies on
the primary health care system and takes advantage of a simple case definition to find sus-
pected cases allowing for an initial diagnosis by non-medical personnel [11]. This allows for
the use of a wide network of community volunteers searching for cases and covering remote
areas where Guinea worm is often found and where it is more difficult for more formal health
workers to reach [11].
Surveillance activities are primarily in humans, although the focus is dependent on the epi-
demiology of the disease; recent increases in identification of cases in animals means surveil-
lance has been expanded in some countries to include dogs [14,16] and surveillance strategies
in wild animals are under consideration.
If the programme does not detect any indigenous cases of Guinea worm for a year it can
move into a three year, pre-certification intensified surveillance stage [27]. This involves con-
tinued active and passive surveillance strategies. If no further cases are identified during this
time period, the country can be certified as free of transmission, however surveillance needs to
be maintained until global eradication is declared [28,29].
In contrast, the verification of the elimination of onchocerciasis aims to interrupt transmis-
sion but not necessarily identify all cases [30]. The onchocerciasis surveillance strategy focuses
on active surveillance and primarily relies on an entomological component, monitoring infec-
tivity rates of black flies and an epidemiological component, tracking exposure to infection in
humans, through sentinel surveillance of villages and breeding sites. The primary indicator for
onchocerciasis is the detection of O. volvulus DNA through O-150 PCR (poolscreen) in black-
flies. Table 2 outlines the indicator in more detail. Serological indicators are also recom-
mended as a complement to the entomological indicator, especially where collection of the
required number of flies is difficult to achieve [31].
Following cessation of mass drug administration (MDA), current recommendations out-
line the need to reassess the entomological indicator, 3–5 years after stopping treatment [31], a
timeframe by which models suggest resurgence is likely to be detected [32]. At this stage, con-
ditional use of serology is recommended only when the entomological threshold is equal to or
close to being achieved [31]. Countries are encouraged to set up National Onchocerciasis
Elimination Committees (NOEC) to provide external review of programme data and provide
advice to the Ministry of Health on how to achieve the elimination of onchocerciasis targets
[31,33].
Finally, there is the validation of trachoma as a public health problem that does not aim to
interrupt transmission and infection and morbidity may occur but at levels that are not
deemed to be a problem at the level of the population [24,34]. Unlike Guinea worm, there is
no imperative to quickly identify cases as for progression of the disease and significant mor-
bidity, an individual would require multiple infections over time. If the programme is able to
ensure transmission of Ct is kept low, potentially in a state of equilibrium, then individuals
should no longer be exposed to the number of infections required to result in significant mor-
bidity [35].
The trachoma surveillance strategy is based on active and passive components, which
involve monitoring clinical indicators in humans [36]. Active trachoma is primarily monitored
through the identification of TF; for diagnosis, the eyelid needs to be everted and assessed by a
trained grader. In comparison TT is easier to diagnose and can be identified by lay persons
with little training [37].
Trachoma surveillance and evidence for validation of elimination as a public health prob-
lem is primarily through conduct of population-based surveys, with the impact assessment to
be carried out at least six months after the last round of MDA with azithromycin [36]. An
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evaluation unit (EU) is usually a district or administrative unit of between 100,000 and 250,000
population, with clusters being a village or an enumeration area. Passive surveillance for tra-
choma is related to the identification and management of incident TT cases [23].
During the pre-validation surveillance phase, the country programme must ensure that
there is an effective system in place to identify and manage incident TT cases, although the spe-
cifics as to how is currently not detailed. A further population-based survey is conducted after
a minimum of two years since the last survey, a timeframe chosen as it is suspected to be the
earliest time-point by which resurgence will be detected at that population-level. This aims to
confirm that elimination thresholds have been maintained and provide evidence for validation
of elimination [23].
For all three diseases it is encouraged to include indicators as part of a country’s health
management information system (HMIS) and national integrated disease and response
(IDSR) system [38].
The biggest gap in current guidance for onchocerciasis and trachoma programmes, is in
relation to post-elimination surveillance. This needs to continue until all countries in the
Table 2. Recommendations on surveillance for eradication of guinea worm and elimination of onchocerciasis and trachoma.
Consideration Guinea worm Onchocerciasis Trachoma
Elimination or
eradication
Eradication Verification of elimination, interruption of
transmission




Number of cases of Guinea worm, defined as a
person exhibiting a skin lesion or lesions with
emergence of one or more worms, ideally that
are laboratory-confirmed at CDC as D.
medinensis. Each infected person is counted as a
case only once during a calendar year
Entomological indicator: proportion of (parous)
flies infected with infective larvae in the head.
Human indicator: a measure of recent exposure
through the identification of a child under 10
with antibodies to Ov-16 antigen.
Prevalence of TF–five or more follicles
(0.5mm or larger) in upper central tarsal
conjunctiva Prevalence of TT–one or more
eyelashes in turned and touching globe of eye
Threshold
targeted
Zero cases globally It is recommended that 6,000 flies from a
transmission zone are tested to provide evidence
that less than 0.1% (<1/1000) parous flies have
infective larvae in the head (upper bound of 95%
confidence interval) or 0.5% (<1/2000) in all
flies, assuming a parity rate of 50%. The black fly
survey should be conducted during peak
transmission season, at least six months after the
last round of MDA [31]. Programmes must aim
to achieve a seroprevalence of less than 0.1% in
children aged under 10, with a minimum sample
size of 2,000.
A TF prevalence of less than 5% in children
aged 1–9 years and a TT prevalence
(unknown to the health system) of less than
0.1% in the total population or 0.2% in adults
aged 15 and above [36]. A TT case is known
to the health system, if they have been
identified by a health worker and refused
surgery or have a date for surgery in place, or




All residing in villages at risk Children under 10 years in areas at highest risk of
recrudescence










On-going door-to-door case searches in
endemic or previously endemic areas or areas at
risk of reintroduction. Led by community
volunteers. Rumour reporting, incentivised with
monetary reward for case finding.
Purposeful sampling to detect infection in black
flies. Conditional use of serological indicator in
children. Led by technical specialists
Population-based survey, randomly selected
clusters. Led by certified graders.
Passive
surveillance




Pre-certification surveillance: 3 years from
identification of last indigenous case
Certification of eradication: surveillance
activities to continue until global eradication
Post-treatment surveillance: 3–5 years
Verification of elimination: surveillance until
countries in region verified elimination
Pre-validation surveillance: 2 years
Validation of elimination with post-
validation elimination indefinitely
https://doi.org/10.1371/journal.pntd.0009082.t002
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region have achieved elimination status in the case of onchocerciasis and indefinitely for tra-
choma, however there is a paucity of information on the optimal methodology to achieve this
and no formal guidelines available to guide country programmes [24,31,39].
A summary of the recommendations for Guinea worm, onchocerciasis and trachoma sur-
veillance strategies is outlined in Table 2.
ii. Comparison of active surveillance approaches
Community-led case surveillance. Active surveillance for Guinea worm is achieved
through community-based door-to-door case finding, with a focus during peak transmission
season. It is conducted in all villages that are endemic, recently endemic or at a high risk of an
imported case [27]. The strategy is relatively simple and flexible in design [40] with community
volunteers having an instrumental role in Guinea worm surveillance activities, leading the case
searches, reporting suspected or rumour cases in a timely manner and compiling monthly
reports on cases identified.
A study in Nigeria evaluated different case search approaches for Guinea worm. It utilised a
mixed methods approach and highlighted the improved specificity and accuracy of case
searches when utilising community reporting at farmers markets over government-led case
searches [41,42]. The study highlighted the need to understand local experiences, community
structures and definitions of a disease, in order to facilitate case searches and reduce misdiag-
nosis. However, evidence from country evaluations conversely suggested a significant false
negative rate when using a community surveillance approach, which highlights the need for
continued and sustained efforts by country programmes to maintain an active and efficient
surveillance system, especially in previously endemic areas [43]. It was not clear at what stage
of the eradication timetable this study was conducted and therefore the value of the results in a
setting where every case needs to be identified and contained promptly is questionable. In
addition, the study was not an RCT and was appraised as having an unclear credibility and
risk of bias.
Community-based door-to-door TT case finding has also been utilised in trachoma pro-
grammes and although this approach is expensive (compared to a passive surveillance or sur-
vey approach) and time-consuming, it has the advantage of finding the majority of TT cases
and allows for immediate case management [44,45]. A community-based randomized con-
trolled trial was conducted in Tanzania and compared the utility of community treatment
assistants (CTA), facilitated with training and use of TT screening cards, to usual care provi-
sion. The authors found that the use of CTAs was a viable method to identify TT cases, and
although sensitivity was only 31.2%, the number of TT cases identified was 5.6 times higher
than in the standard care approach. The study also recommended further efforts to reduce the
number of false positives identified [37].
The importance of extending community surveillance strategies to cover cross-border areas
[46], nomadic, migratory or traveller populations has been highlighted. A study in Nigeria, uti-
lised a targeted case search for Guinea worm cases amongst the nomadic Fulani community
and highlighted the need to develop a targeted approach to identify and include nomadic
groups in surveillance [47]. A study in Tanzania, evaluated an enhanced surveillance system
targeting newcomers and travellers in reducing prevalence of Ct infection. A total of 52 com-
munities were randomised to either receive annual MDA if warranted or annual MDA again if
warranted but with enhanced surveillance to identify and treat infection amongst newcomers
and travellers. There was no strong evidence to suggest a difference in the change in infection
prevalence amongst the two arms [48].
There appears to be utility in using community surveillance strategies either with paid com-
munity health workers (existing in health system structure) or community volunteers.
PLOS NEGLECTED TROPICAL DISEASES Trachoma elimination surveillance, lessons from guinea worm and onchocerciasis strategies
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0009082 January 28, 2021 8 / 20
However, there are issues with the sustainability of using the latter, especially if they are offered
limited incentives and where support supervision is limited, or the quality is unsatisfactory.
The assimilation of the community volunteers into other health programmes such as trachoma
could potentially improve motivation [43,49]. However, there is also the potential to overbur-
den volunteers and ignore the opportunity and replacement costs for the volunteer of their
unpaid time [50].
Rumour reporting and reward systems. To address inherent weaknesses in the Guinea
worm endgame, especially under-reporting of individual cases, often rural and further from
health facilities [27,51], one system employed to improve case detection has been establish-
ment of a rumour register and a cash reward system set up for voluntary reporting of a con-
firmed case [11]. In some countries, the reward system has been extended to encourage the
reporting of and tethering of infected dogs [14].
There are suggestions that in Chad the introduction and dissemination of the monetary
reward system for identifying a case, as part of the pre-certification activities, led to the identi-
fication of the 2010 outbreak. It is unclear whether this was an example of the re-introduction
of the disease or there had been low level transmission since 2000 that was not detected by the
previous surveillance system in place [14]. A disadvantage of using a rumour reporting system
and a large cash reward incentive is that it can result in a high number of false positives
reported through the system. Investigation of a total of 528 rumours of Guinea worm reported
in Nigeria in 2008, identified no true cases of Guinea worm amongst them, with the majority
of cases being a boil, ulcer or sore (30%) or rheumatism or arthritis (16%) [52]. There were no
trials reported assessing the effectiveness of reward systems in identifying cases. Limited evi-
dence from the utilisation of CTAs in Tanzania, also suggests the issue of substantial false posi-
tive cases for identification of TT cases using community volunteers and this is a significant
limitation [37], with expectations this would only be exacerbated by the introduction of mone-
tary incentives for reporting of cases.
Sentinel surveillance. Onchocerciasis surveillance is led by specialist technicians and
involves the repeat monitoring of the sentinel sites in a transmission zone, which are purpose-
fully selected, often biased to areas with the suspected highest onchocerciasis prevalence [53].
If local knowledge of the disease is not well known or there are changing ecological factors that
have not been realised, then it may miss significant areas of residual transmission [54]. No
studies were identified detailing research evaluating the sensitivity or specificity of the sam-
pling strategies.
The WHO guidance for trachoma pre-validation surveillance shifted from purposeful sur-
veillance of a limited number of sites targeted to areas believed to be the most likely endemic
or with risk factors for trachoma. In 2014, the guidance was updated, shifting away from active
on-going surveillance of TF because risk factors for trachoma are not well understood at the
community level and there is a lack of community data for those that are known. Ultimately it
was felt that such a strategy may result in data influenced by bias and chance effect [36]. How-
ever, there may be a role for more purposeful surveillance in a post-validation setting, where
resources are limited.
Population-based survey
For the decision to stop treatment and for validation of elimination, trachoma utilises a popu-
lation-based survey, with approximately 30 randomly selected clusters in each EU [36]. Efforts
have been made to provide a standardised protocol and methodology for conduct of the sur-
veys, spearheaded by the Global Trachoma Mapping Project [55]. The spatial resolution for
prevalence estimates for trachoma is much lower than for Guinea worm and onchocerciasis.
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The population-based surveillance survey is powered to the level of the EU, usually a district. It
may miss smaller foci of recrudescence that are emerging, although evidence to date suggests
that sub-district re-emergence does not necessarily impact on neighbouring sub-districts [36].
Further evidence is required to understand the implications of community and sub-district
persistent infection or recrudescence and methodologies to detect it, especially post-
validation.
TT prevalence estimates from the population-based surveys are also reported but the survey
is not powered to determine if the TT thresholds have been realised [55]. To do this with the
required confidence would require a survey with a larger sample size, such as outlined in a TT
only survey [56], although there is still a risk that such a strategy would result in a prevalence
estimate with confidence intervals inclusive of the target threshold.
In general, trachoma surveys exclude urban areas from their sampling frame. However,
with increasing urbanisation leading to an exacerbation of social and sanitation problems,
known to be a risk factor for trachoma, combined with an influx of people from more rural
areas who may introduce trachoma, this may lead to unidentified transmission pockets. A
cross-sectional survey was conducted in an urban community in Gambia and although TF
prevalence was below the elimination thresholds there were communities identified with a TF
prevalence of over 5% and TT remains a public health problem (over 0.1%), with the authors
concluding it would be prudent to include similar urban or peri-urban areas in surveillance
activities [57].
A comparison of the various active surveillance strategies are summarised in Table 3.
iii. Diagnostics
This review focused on the opportunities and limitations of using infection and serological
testing for surveillance, as reported in the literature. Specific papers evaluating different diag-
nostic tests were outside the scope of this review.
Test for infection. Both Guinea worm and onchocerciasis surveillance include a test for
infection within their surveillance strategy. For Guinea worm this has been introduced latterly
as numbers of Guinea worm cases have reduced and worms emerge in isolation. Retrieved
Guinea worms are subject to molecular testing and evaluation of the morphology of the worm
[14,28] to confirm they are D. medinensis and not confused with other worms e.g O. volvulus
[59,60].
The primary indicator for onchocerciasis, relating to infectivity in black flies, is measured
through PCR testing for O. volvulus. This has the advantage that it is a very specific test and
can distinguish between the human infection and O. ochengi that can be found in cattle [31]. A
key disadvantage is that PCR for detection of O. volvulus in flies is not readily available, with
only a few laboratories having the technical capacity to conduct the test, especially in oncho-
cerciasis endemic countries [54]. There are also significant costs associated with black fly DNA
testing, although this is mitigated in part, through the use of pool screening [31].
For trachoma where a low pathogen load is unlikely to lead to transmission of infection and
where a low level of on-going transmission is in line with elimination as a public health prob-
lem, the specificity of the surveillance system has been deemed critical [12]. However, it is
known there are issues with the specificity of the clinical indicator in low prevalence settings
with a discordance between TF and ocular Ct infection [61–64] and subjectivity in the inter-
grader agreement for borderline TF cases [36]. Current evidence from an elimination setting
where TF is very low, at only 1 or 2% and well below the 5% elimination threshold, has shown
Ct infection to be very low or non-detectable [65,66]. Therefore, in this context, current evi-
dence suggests direct evaluation of ocular infection does not make a difference to program-
matic decision-making or validation of elimination but may delay results and a timely
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Table 3. Summary of studies evaluating evidence of surveillance strategies and implications for trachoma surveillance.
Surveillance
strategy
Summary current evidence Implications for trachoma
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response. However, current guidelines would denote an EU where the TF prevalence estimate
rose from 4.9% to 5.1% as having fit the criteria for recrudescence, even if the lower bound
95% confidence interval of the estimate dipped below 5.0%. As TF can also be a symptom of
other infections or there can be a delay in TF disappearing even when Ct infection has been
cleared, the evaluation of Ct infection, especially where there are prevalence estimates close to
the threshold cut-off can be used to clarify if there is true recrudescence of trachoma that
would require programmatic intervention.
Serological test. Onchocerciasis is the only one of the three diseases that has a specific sero-
logical target for surveillance. In low prevalence settings or post-treatment, the use of serology
(anti Ov-16 antibodies) is deemed more sensitive [31,67] for monitoring transmission than the
use of microscopy to identify microfilariae in skin snips, which historically have been the main-
stay of onchocerciasis monitoring in humans. Rapid antibody tests have also been shown to be
preferable to the community, with an evaluation in Senegal highlighting improved participation
for the antibody test, with 99.7% uptake as compared to 32.7% for the skin snip biopsy [68].
A serologic target can not distinguish between current infection and past exposure. How-
ever, for onchocerciasis, it is expected that children aged 10 and under will be infection naïve if
the programme has been successful in suppressing transmission (over a 10 year period or life
of adult worm) [69]. The assumption is that all infections lead to seroconversion, however a
significant proportion of individuals (15–25%) have been found to not illicit an anti Ov-16
immune response [70]. Although a low target threshold may help to counteract this loss in sen-
sitivity, any target chosen must be achievable. The target for onchocerciasis programmes
(<0.1% seroprevalence in children under 10) would require a diagnostic test with consistently
greater than 99.9% specificity, which is not possible with current platforms available to country
programmes [67]. For this reason, the target is currently under review.
Finally, the methodology used to determine a seropositive individual makes a difference to
the overall seroprevalence estimates in a population [71], yet the onchocerciasis guidelines do
not specify the test required (rapid test or ELISA) to determine an Ov16 seropositive individ-
ual nor the methodology to determine seropositive thresholds [31]. In trachoma endemic
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historical transmission dynamics and potentially earmark areas at risk of recrudescence, which
can be monitored more closely as part of a post-validation surveillance strategy [65,66,72–76].
The main disadvantage is that the currently favoured antibody of interest (anti-Pgp3) can not
distinguish between urogenital or ocular chlamydia and there are still gaps in the understand-
ing of an individual’s immunological response [77]. To date, clinical indicators continue to be
the only diagnostic recommended for programmatic decision-making.
A summary of the considerations for laboratory confirmation of trachoma infection and
exposure is highlighted in Table 4.
Discussion
Due to the clinical progression of trachoma, with the active infectious form of trachoma and
TT, the progression of the disease, adds complexity to trachoma, with two related but
Table 4. Summary of studies evaluating use of laboratory confirmation for surveillance.
Surveillance
strategy
Summary of current evidence (elimination setting) Implications for
trachoma
surveillance
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morphologically different presentations, which require alternative surveillance strategies. Tra-
choma pre-validation surveillance has three key functions, firstly the monitoring of trachoma
to determine if elimination thresholds have been achieved, the identification of any recrudes-
cence in a timely manner and finally the identification and management of incident TT cases
[36]. There are a number of lessons learnt from the Guinea worm surveillance system that are
particularly compatible for TT surveillance while the onchocerciasis surveillance strategy can
provide insights for surveillance of the active infectious form of trachoma.
For Guinea worm where the target is eradication, it is important to have a sensitive system
that is able to detect cases in a timely manner, a goal facilitated by rumour reporting and the
reward scheme for reporting of a confirmed case of Guinea worm and the exhaustive door-to-
door case search using community volunteers. Although trachoma is not an eradication pro-
gramme it would be preferable if a programme was able to identify and manage all cases of tri-
chiasis, as the condition is painful and can lead to sight loss if left untreated. Currently TT
elimination thresholds are primarily monitored through a survey methodology, which can
lead to imprecise prevalence estimates. In addition, passive surveillance systems have been
shown to under-estimate TT cases [45]. Ghana and other countries including Morocco [45,78]
have successfully used door-to-door case searches to identify TT cases and more accurately
determine if TT elimination thresholds have been met. However, due to the cost and logistical
implications, it is necessary to be strategic as to when and where such strategies are employed.
The utility of the reward system, as used in Guinea worm surveillance, to identify trichiasis
cases, which can be diagnosed by non-medical personnel, may be an interesting application
requiring further exploration. However, the use of community volunteers to identify TT cases
has already been shown to result in a high proportion of false positive cases being referred [37]
and there is a risk that implementing such a reward system would exacerbate this problem. As
there is little objective evidence as to the effectiveness of the reward system in identifying con-
firmed cases of Guinea worm and previously unknown foci of transmission, a suitably
designed RCT, with appropriate formative research understanding motivational factors for
case finding, would be beneficial to evaluate the evidence of the effectiveness of this approach
for TT case finding.
The specificity of a trachoma surveillance system is critical in order to ensure elimination
targets are effectively determined and interventions are not prolonged, wasting limited
resources [12]. The onchocerciasis surveillance system has had a key focus on introducing
appropriate diagnostic tests to measure transmission parameters, primarily infection in black
flies and serological markers in humans. However, the tests introduced have been complex,
with restricted global capacity to implement, which can unduly delay programme decision
making. The target thresholds have not been based on sound evidence and the serological tar-
gets are practically unattainable with current diagnostic tests [67].
Detection of ocular Ct infection through PCR in trachoma has been shown to be useful in
understanding the true infection rates [61,62,64,65] but is expensive, although pooling of sam-
ples for analysis can mitigate the cost to an extent [79–81]; so will likely be better targeted as a
resource, for instance to determine true levels of infection in EUs with a TF prevalence close to
the elimination threshold.
The current serological threshold for verification of elimination of onchocerciasis is<0.1%
in children under 10 years. Although a direct comparison can not be made, in part because the
aim for trachoma is not interruption of transmission, evidence from modelling suggests a suit-
able serological threshold for trachoma that equates to a TF prevalence of<5% in children
aged 1–9 years, would be a seroprevalence (anti-Pgp3 antibodies) of 7.3% (95%CI: 6.5–8.3)
[82]. The use of a fixed serological cut-off for a measure of exposure, that encompasses a wide
age range can have issues, as historical transmission and the long antibody half-lives, can lead
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to a misinterpretation of findings. Further the cross-reactivity of the antibodies to multiple
antigens, whether it be other filaria or in the case of trachoma, urogenital chlamydia, means
that epidemiological context must be taken into account when determining serological cut-
offs. There is potentially greater utility in using serology as an indicator of recent transmission
dynamics [83] and for aiding the identification of areas at potential increased risk of recrudes-
cence [65,71,72]. Serology is also a useful indicator as it can easily be integrated with the moni-
toring of other infectious diseases [12,84]. However, there are a number of factors that need to
be considered before any recommendations to include infection or serological marker within
trachoma surveillance, including a standardised methodology for determining a seropositive
individual (76) and a network of laboratories that can conduct serological tests with necessary
proficiency or a point of care or rapid test that would negate it.
Trachoma currently utilises a population-based survey methodology for validation of elimi-
nation. Purposeful selection of sentinel sites as a surveillance strategy is no longer recom-
mended pre-validation [36]. However, there is potential utility of a more targeted surveillance
approach in a post-validation setting, where population-based survey approaches are not war-
ranted. Such an approach could focus on surveillance of communities at increased risk of
recrudescence. Further work is required to understand the risk factors and assist in defining
targets for surveillance, however, the use of infection and serology data shows potential prom-
ise as a strategy [65], potentially as part of an adaptive sampling approach.
It would have been useful to frame this paper based on the elimination dossiers of the ten
countries that have been validated as having eliminated trachoma as a public health problem,
however, very few were publicly available. The literature search highlighted very few published
papers evaluating the integration of surveillance systems into more established care pathways,
something that is likely to be key for sustainable surveillance in the endgame and a topic that
this review would have benefited from further discussion on. The paper also only reviews les-
sons learnt from two NTDs and it could be useful to extend such a review to include other per-
tinent diseases, for example lymphatic filariasis, that also has a surveillance system that
requires monitoring of infection and chronic morbidity. Finally, the literature review method-
ology utilised for this paper was not intended to be that of a systematic review, however, the
authors still aimed to ensure a rigorous methodology, with clear inclusion and exclusion crite-
ria and an assessment of the credibility and risk of bias amongst papers included in order to
understand the strength of evidence available. It is felt that this approach has highlighted some
interesting lessons learnt, as well as inform current evidence gaps that would be useful for fur-
ther research.
Conclusion
The experiences of both the Guinea worm and onchocerciasis surveillance strategies have very
useful lessons for trachoma surveillance, pre- and post-validation. The use of a monetary
reward for identification of TT cases and further exploration into the use of infection and sero-
logical indicators particularly in a post-validation setting to assist in identifying recrudescence
would be of particular relevance. The next step would be a real-world evaluation of their rela-
tive applicability for trachoma surveillance.
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onchocerciasis in Côte d’Ivoire following 40 years of intervention: Progress and challenges. PLoS NTD.
2018; 12(10):e0006897. https://doi.org/10.1371/journal.pntd.0006897 PMID: 30352058
54. Cantey PT, Roy SL, Boakye D, Mwingira U, Ottesen EA, Hopkins AD, et al. Transitioning from river
blindness control to elimination: steps toward stopping treatment. Int Hlth. 2018; 10(suppl_1):i7–i13.
https://doi.org/10.1093/inthealth/ihx049 PMID: 29471338
55. Solomon AW, Pavluck AL, Courtright P, Aboe A, Adamu L, Alemayehu W, et al. The Global Trachoma
Mapping Project: Methodology of a 34-Country Population-Based Study. Ophthalmic Epi. 2015; 22
(3):214–25. https://doi.org/10.3109/09286586.2015.1037401 PMID: 26158580
56. WHO Strategic and Technical Advisory Group on Neglected Tropical Diseases. Design and validation
of a trachomatous trichiasis-only survey (WHO/HTM/NTD/PCT/2017.08). Geneva: WHO; 2018.
57. Quicke E, Sillah A, Harding-Esch EM, Last A, Joof H, Makalo P, et al. Follicular trachoma and trichiasis
prevalence in an urban community in The Gambia, West Africa: is there a need to include urban areas
in national trachoma surveillance? TM & IH. 2013; 18(11):1344–52.
58. Renewed transmission of dracunculiasis—Chad, 2010. MMWR Morb Mortal Wkly Rep. 2011; 60
(22):744–8. PMID: 21659983
59. Eberhard ML, Melemoko G, Zee AK, Weisskopf MG, Ruiz-Tiben E. Misidentification of Onchocerca vol-
vulus as guinea worm. Ann Trop Med Parasitol. 2001; 95(8):821–6. https://doi.org/10.1080/
00034980120103397 PMID: 11784436
60. Eberhard ML, Ruiz-Tiben E, Korkor AS, Roy SL, Downs P. Emergence of Onchocerca volvulus from
skin mimicking Dracunculiasis medinensis. Am J Trop Med & Hlth. 2010; 83(6):1348–51. https://doi.
org/10.4269/ajtmh.2010.10-0475 PMID: 21118947
PLOS NEGLECTED TROPICAL DISEASES Trachoma elimination surveillance, lessons from guinea worm and onchocerciasis strategies
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0009082 January 28, 2021 18 / 20
61. Solomon AW, Harding-Esch E, Alexander ND, Aguirre A, Holland MJ, Bailey RL, et al. Two doses of azi-
thromycin to eliminate trachoma in a Tanzanian community. NEJM. 2008; 358(17):1870–1. https://doi.
org/10.1056/NEJMc0706263 PMID: 18434662
62. Burton MJ, Holland MJ, Makalo P, Aryee EA, Sillah A, Cohuet S, et al. Profound and sustained reduc-
tion in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic com-
munities. PLoS NTD. 2010; 4(10):e835. https://doi.org/10.1371/journal.pntd.0000835 PMID: 20957147
63. Keenan JD, Lakew T, Alemayehu W, Melese M, Porco TC, Yi E, et al. Clinical activity and polymerase
chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma.
Am J Trop Med & Hyg. 2010; 82(3):482–7. https://doi.org/10.4269/ajtmh.2010.09-0315 PMID:
20207878
64. Burr SE, Hart JD, Edwards T, Baldeh I, Bojang E, Harding-Esch EM, et al. Association between ocular
bacterial carriage and follicular trachoma following mass azithromycin distribution in The Gambia. PLoS
NTD. 2013; 7(7):e2347. https://doi.org/10.1371/journal.pntd.0002347 PMID: 23936573
65. Senyonjo LG, Debrah O, Martin DL, Asante-Poku A, Migchelsen SJ, Gwyn S, et al. Serological and
PCR-based markers of ocular Chlamydia trachomatis transmission in northern Ghana after elimination
of trachoma as a public health problem. PLoS NTD. 2018; 12(12):e0007027–e. https://doi.org/10.1371/
journal.pntd.0007027 PMID: 30550537
66. West SK, Zambrano AI, Sharma S, Mishra SK, Munoz BE, Dize L, et al. Surveillance Surveys for Ree-
mergent Trachoma in Formerly Endemic Districts in Nepal From 2 to 10 Years After Mass Drug Admin-
istration Cessation. JAMA Ophthalmol. 2017; 135(11):1141–6. https://doi.org/10.1001/jamaophthalmol.
2017.3062 PMID: 28973295
67. Gass KM. Rethinking the serological threshold for onchocerciasis elimination. PLoS NTD. 2018; 12(3):
e0006249. https://doi.org/10.1371/journal.pntd.0006249 PMID: 29543797
68. Dieye Y, Storey HL, Barrett KL, Gerth-Guyette E, Di Giorgio L, Golden A, et al. Feasibility of utilizing the
SD BIOLINE Onchocerciasis IgG4 rapid test in onchocerciasis surveillance in Senegal. PLoS NTD.
2017; 11(10):e0005884.
69. Unnasch TR, Golden A, Cama V, Cantey PT. Diagnostics for onchocerciasis in the era of elimination.
Int Hlth. 2018; 10(suppl_1):i20–i6. https://doi.org/10.1093/inthealth/ihx047 PMID: 29471336
70. Gbakima AA, Nutman TB, Bradley JE, McReynolds LA, Winget MD, Hong Y, et al. Immunoglobulin G
subclass responses of children during infection with Onchocerca volvulus. Clin Diagn Lab Immunol.
1996; 3(1):98. PMID: 8770512
71. Migchelsen SJ, Martin DL, Southisombath K, Turyaguma P, Heggen A, Rubangakene PP, et al. Defin-
ing Seropositivity Thresholds for Use in Trachoma Elimination Studies. PLoS NTD 2017; 11(1):
e0005230. https://doi.org/10.1371/journal.pntd.0005230 PMID: 28099433
72. Migchelsen SJ, Sepulveda N, Martin DL, Cooley G, Gwyn S, Pickering H, et al. Serology reflects a
decline in the prevalence of trachoma in two regions of The Gambia. Sci Rep. 2017; 7(1):15040. https://
doi.org/10.1038/s41598-017-15056-7 PMID: 29118442
73. Martin DL, Bid R, Sandi F, Goodhew EB, Massae PA, Lasway A, et al. Serology for trachoma surveil-
lance after cessation of mass drug administration. PLoS NTD. 2015; 9(2):e0003555. https://doi.org/10.
1371/journal.pntd.0003555 PMID: 25714363
74. Gwyn SE, Xiang L, Kandel RP, Dean D, Gambhir M, Martin DL. Prevalence of Chlamydia trachomatis-
Specific Antibodies before and after Mass Drug Administration for Trachoma in Community-Wide Sur-
veys of Four Communities in Nepal. Am J Trop Med & Hyg. 2018; 98(1):216–20.
75. Kim JS, Oldenburg CE, Cooley G, Amza A, Kadri B, Nassirou B, et al. Community-level chlamydial
serology for assessing trachoma elimination in trachoma-endemic Niger. PLoS NTD. 2019; 13(1):
e0007127. https://doi.org/10.1371/journal.pntd.0007127 PMID: 30689671
76. West SK, Munoz B, Weaver J, Mrango Z, Dize L, Gaydos C, et al. Can We Use Antibodies to Chlamydia
trachomatis as a Surveillance Tool for National Trachoma Control Programs? Results from a District
Survey. PLoS NTD. 2016; 10(1):e0004352. https://doi.org/10.1371/journal.pntd.0004352 PMID:
26771906
77. Chen D, Lei L, Lu C, Galaleldeen A, Hart PJ, Zhong G. Characterization of Pgp3, a Chlamydia tracho-
matis plasmid-encoded immunodominant antigen. J Bacteriol. 2010; 192(22):6017–24. https://doi.org/
10.1128/JB.00847-10 PMID: 20851898
78. Hammou J, El Ajaroumi H, Hasbi H, Nakhlaoui A, Hmadna A, El Maaroufi A. In Morocco, the elimination
of trachoma as a public health problem becomes a reality. Lancet Glob Health. 2017; 5(3):e250–e1.
https://doi.org/10.1016/S2214-109X(17)30023-2 PMID: 28089329
79. Diamant J, Benis R, Schachter J, Moncada J, Pang F, Jha HC, et al. Pooling of Chlamydia laboratory
tests to determine the prevalence of ocular Chlamydia trachomatis infection. Ophthalmic Epidemiol.
2001; 8(2–3):109–17. https://doi.org/10.1076/opep.8.2.109.4156 PMID: 11471080
PLOS NEGLECTED TROPICAL DISEASES Trachoma elimination surveillance, lessons from guinea worm and onchocerciasis strategies
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0009082 January 28, 2021 19 / 20
80. Dize L, West SK, Mkocha H, Quinn TC, Gaydos CA. Evaluation of pooled ocular and vaginal swabs by
the Cepheid GeneXpert CT/NG assay for the detection of Chlamydia trachomatis and Neisseria gonor-
rhoeae compared to the GenProbe Aptima Combo 2 Assay. Diagn Microbiol Infect Dis. 2015; 81
(2):102–4. https://doi.org/10.1016/j.diagmicrobio.2014.11.010 PMID: 25497459
81. Lewis JL, Lockary VM, Kobic S. Cost savings and increased efficiency using a stratified specimen pool-
ing strategy for Chlamydia trachomatis and Neisseria gonorrhoeae. J Sex Trans Dis. 2012; 39(1):46–8.
https://doi.org/10.1097/OLQ.0b013e318231cd4a PMID: 22183846
82. Pinsent A, Solomon AW, Bailey RL, Bid R, Cama A, Dean D, et al. The utility of serology for elimination
surveillance of trachoma. Nat Comms. 2018; 9(1):5444.
83. Pinsent A, Hollingsworth TD. Optimising sampling regimes and data collection to inform surveillance for
trachoma control. PLoS NTD. 2018; 12(10):e0006531–e. https://doi.org/10.1371/journal.pntd.0006531
PMID: 30307939
84. Vlaminck J, Fischer PU, Weil GJ. Diagnostic Tools for Onchocerciasis Elimination Programs. Trends
Parasitol. 2015; 31(11):571–82. https://doi.org/10.1016/j.pt.2015.06.007 PMID: 26458784
PLOS NEGLECTED TROPICAL DISEASES Trachoma elimination surveillance, lessons from guinea worm and onchocerciasis strategies
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0009082 January 28, 2021 20 / 20
